Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Breast cancer

Risk of heart disease after radiotherapy—cause for concern

Radiotherapy is known to cause heart disease. A recent analysis challenges several long-held tenets, indicating that radiation-induced cardiotoxicity might occur at lower doses, and earlier, than generally believed. We must be mindful of this toxicity and limit cardiac radiation dose as much as possible.

Key Points

  • Low planned doses of radiotherapy are associated with the development of ischaemic heart disease (absolute increase is small), with an interval between exposure and the development of disease shorter than previously accepted (years, not decades)

  • Radiation oncologists have modern techniques that markedly reduce the dose of ionizing radiation to the heart when compared with older techniques; the therapeutic ratio of radiation is likely to be higher with more modern techniques

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The approximate cardiac doses associated with various selected techniques used to treat left-sided breast cancer are shown, evolving over time from left to right.

References

  1. Darby, S. C. et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368, 987–998 (2013).

    Article  CAS  Google Scholar 

  2. Taylor, C. W., Nisbet, A., McGale, P. & Darby, S. C. Cardiac exposures in breast cancer radiotherapy: 1950s–1990s. Int. J. Radiat. Oncol. Biol. Phys. 69, 1484–1495 (2007).

    Article  Google Scholar 

  3. Taylor, C. W. et al. Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. Radiother. Oncol. 90, 127–135 (2009).

    Article  Google Scholar 

  4. Marks, L. B. et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int. J. Radiat. Oncol. Biol. Phys. 63, 214–223 (2005).

    Article  Google Scholar 

  5. Taylor, C. W. et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001 Radiother. Oncol. 100, 176–183 (2011).

    Article  Google Scholar 

  6. Giordano, S. H. et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J. Natl Cancer Inst. 97, 419–424 (2005).

    Article  Google Scholar 

  7. Clarke, M. et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366, 2087–2106 (2005).

    Article  CAS  Google Scholar 

  8. Lymberis, S. C. et al. Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int. J. Radiat. Oncol. Biol. Phys. 84, 902–909 (2012).

    Article  Google Scholar 

  9. Chino, J. P. & Marks, L. B. Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int. J. Radiat. Oncol. Biol. Phys. 70, 916–920 (2008).

    Article  Google Scholar 

  10. Schubert, L. K. et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother. Oncol. 100, 241–246 (2011).

    Article  Google Scholar 

Download references

Acknowledgements

T. M. Zagar and L. B. Marks acknowledge support from the National Institutes of Health (grant CA69579).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy M. Zagar.

Ethics declarations

Competing interests

The Department of Radiation Oncology at the University of North Carolina receives grant support from Elekta, Morphormics, Siemens and Vision RT.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zagar, T., Marks, L. Risk of heart disease after radiotherapy—cause for concern. Nat Rev Clin Oncol 10, 310–312 (2013). https://doi.org/10.1038/nrclinonc.2013.59

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2013.59

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer